[1
]IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr.
Bohrgasse 3, A-1030 Vienna, Austria
[2
]Medical Research Institute, Tokyo Medical and Dental University, Kandasurugadai 2-3-10,
Chiyoda-ku, Tokyo 101-0062, Japan
[3
]CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences and
Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna,
Währinger Gürtel 18-20, A-1090 Vienna, Austria
[4
]European Molecular Biology Laboratory (EMBL), Mouse Biology Unit, Via Ramarini 32,
Monterotondo-Scalo, Rome 00016, Italy
[5
]Institute for Genetics, University of Cologne, Zülpicher Str. 47, D-50674 Cologne,
Germany
[6
]Lawson Health Research Institute, Departments of Medicine and Physiology and Pharmacology,
The University of Western Ontario, London Ontario, N6A 4V2, Canada
[7
]Department of Pathology, University of Hong Kong, SAR
[8
]Department of Microbiology, University of Hong Kong, SAR
[9
]National Key Laboratory of Medical Molecular Biology, School of Basic Medicine Peking
Union Medical College and Chinese Academy of Medical Sciences, Beijing 100005, China
[10
]Molecular Biomedicine, Swiss Federal Institute of Technology, Wagistrasse 27, CH-8952
Zürich-Schlieren, Switzerland
[11
]US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick,
MD 21701, USA
[12
]Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto
M5B 1W8, Canada
[13
]Department of Critical Care, St. Michael's Hospital, University of Toronto, Toronto
M5B 1W8, Canada
[14
]Department of Host Defense, Research Institute for Microbial Diseases, Osaka University,
Osaka 565-0871, Japan
[15
]Medical Inflammation Research, MBB, Karolinska Institutet, Stockholm, Sweden and Medical
Inflammation Research BMC I11 Lund, Sweden
License:
Since January 2020 Elsevier has created a COVID-19 resource centre with free information
in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre
is hosted on Elsevier Connect, the company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre - including this research content - immediately
available in PubMed Central and other publicly funded repositories, such as the WHO
COVID database with rights for unrestricted research re-use and analyses in any form
or by any means with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre remains active.